General Information
Revision date
2016-01-14
Product name
B10029800
CAS No.
16752-77-5
Manufacturer Name
E.I. du Pont Canada Company
Icons in SDS
Company Information
company name
E.I. du Pont Canada Company
Section 2
SECTION 2: Hazards identification
OSHA Emergency Overview Warning symptoms: Poisoning produces effects associated with anticholinesterase activity which may include: Weakness, Blurred vision, Headache, Nausea, Abdominal pain, discomfort in the chest, constriction of pupils, Sweating, slow pulse, muscle twitching
Potential health effects
Skin Methomyl : May cause acute acetyl cholinesterase depression. Symptoms and signs include headache, dizziness, fatigue, muscular weakness, drowsiness and in extreme cases, loss of consciousness., Nausea, Abdominal pain, Abnormal tearing, Abnormal salivation, constriction of pupils, Blurred vision, muscle twitching, Convulsions, Respiratory effects. Eyes Methomyl : May irritate eyes. May cause acute acetyl cholinesterase depression., Abnormal tearing, constriction of pupils, Blurred vision. Inhalation Methomyl : May cause acute acetyl cholinesterase depression. Symptoms and signs include headache, dizziness, fatigue, muscular weakness, drowsiness and in extreme cases, loss of consciousness., Nausea, Abdominal pain, Abnormal tearing, Abnormal salivation, constriction of pupils, Blurred vision, muscle twitching, Convulsions, Respiratory effects. Ingestion Methomyl : May cause acute acetyl cholinesterase depression. Symptoms and signs include headache, dizziness, fatigue, muscular weakness, drowsiness and in extreme cases, loss of consciousness., Nausea, Abdominal pain, Abnormal tearing, Abnormal salivation, constriction of pupils, Blurred vision, muscle twitching, Convulsions, Respiratory effects. Target Organ Methomyl Central nervous system Carcinogenicity None of the components present in this material at concentrations equal to or greater than 0.1% are listed by IARC, NTP, or OSHA, as a carcinogen.